Fabino Life Sciences (BOM:543444) COGS-to-Revenue : 0.96 (As of Sep. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Fabino Life Sciences COGS-to-Revenue?

Fabino Life Sciences's Cost of Goods Sold for the six months ended in Sep. 2023 was ₹124.0 Mil. Its Revenue for the six months ended in Sep. 2023 was ₹128.6 Mil.

Fabino Life Sciences's COGS to Revenue for the six months ended in Sep. 2023 was 0.96.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Fabino Life Sciences's Gross Margin % for the six months ended in Sep. 2023 was 3.60%.

Fabino Life Sciences COGS-to-Revenue Historical Data

The historical data trend for Fabino Life Sciences's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fabino Life Sciences COGS-to-Revenue Chart

Fabino Life Sciences Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

COGS-to-Revenue

0.67

0.92

0.89

0.85

0.88

Fabino Life Sciences Semi-Annual Data
	Mar19	Mar20	Mar21	Mar22	Sep22	Mar23	Sep23
COGS-to-Revenue	Get a 7-Day Free Trial			-	-	0.80	0.91	0.96

Fabino Life Sciences COGS-to-Revenue Calculation

Fabino Life Sciences's COGS to Revenue for the fiscal year that ended in Mar. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	29.503	/	33.601
	=	0.88

Fabino Life Sciences's COGS to Revenue for the quarter that ended in Sep. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	123.977	/	128.612
	=	0.96

Fabino Life Sciences (BOM:543444) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Fabino Life Sciences's Gross Margin % for the six months ended in Sep. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	123.977 / 128.612
	=	3.60 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Fabino Life Sciences COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Fabino Life Sciences's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Fabino Life Sciences (BOM:543444) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fabino Life Sciences Ltd (BOM:543444) » Definitions » COGS-to-Revenue

Traded in Other Exchanges

N/A

Address

Murthal Road,, Shubham Garden, Jeevan Vihar Extension Near, Sonipat, HR, IND, 131001

Website

https://www.fabinolife.com

Fabino Life Sciences Ltd is a pharmaceutical company. It is engaged in manufacturing, marketing, trading and packing of pharmaceutical and other wellness-focused consumer products. It offers a wide range of allopathic, Food and wellness, Veterinary, Multi-vitamin and herbal products. The company currently supplies in Haryana, Delhi, parts of Punjab, Himachal Pradesh, Eastern Uttar Pradesh, Orissa, and Jharkhand, and parts of West Bengal, Andhra Pradesh, and Nepal.

Fabino Life Sciences (BOM:543444) Headlines

No Headlines